Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2011, Article ID 840194, 8 pages
http://dx.doi.org/10.1155/2011/840194
Research Article

Involvement of the Retinoid X Receptor Ligand in the Anti-Inflammatory Effect Induced by Peroxisome Proliferator-Activated Receptor 𝜸 Agonist In Vivo

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tsushima-naka 1-1-1, Kita-ku, Okayama 700-8530, Japan

Received 12 July 2011; Accepted 13 September 2011

Academic Editor: J. K. Reddy

Copyright © 2011 Atsuki Yamamoto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. A. Kliewer, B. M. Forman, B. Blumberg et al., “Differential expression and activation of a family of murine peroxisome proliferator-activated receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 15, pp. 7355–7359, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. D. J. Mangelsdorf, C. Thummel, M. Beato et al., “The nuclear receptor super-family: the second decade,” Cell, vol. 83, no. 6, pp. 835–839, 1995. View at Google Scholar · View at Scopus
  3. M. Ricote, A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass, “The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation,” Nature, vol. 391, no. 6662, pp. 79–82, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. L. A. Moraes, L. Piqueras, and D. Bishop-Bailey, “Peroxisome proliferator-activated receptors and inflammation,” Pharmacology and Therapeutics, vol. 110, no. 3, pp. 371–385, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. J. Xu, S. W. Barger, and P. D. Drew, “The PPAR-γ agonist 15-deoxy-Δ 12, 14-prostaglandin J2 attenuates microglial production of IL-12 family cytokines: potential relevance to Alzheimer's disease,” PPAR Research, vol. 2008, Article ID 349185, 2008. View at Publisher · View at Google Scholar · View at PubMed
  6. X. Y. Yang, L. H. Wang, and W. L. Farrar, “A role for PPARγ in the regulation of cytokines in immune cells and cancer,” PPAR Research, vol. 2008, Article ID 961753, 2008. View at Publisher · View at Google Scholar · View at PubMed
  7. A. Nakajima, K. Wada, H. Miki et al., “Endogenous PPARγ mediates anti-inflammatory activity in murine ischemia-reperfusion injury,” Gastroenterology, vol. 120, no. 2, pp. 460–469, 2001. View at Google Scholar · View at Scopus
  8. T. Shiojiri, K. Wada, A. Nakajima et al., “PPARγ ligands inhibit nitrotyrosine formation and inflammatory mediator expressions in adjuvant-induced rheumatoid arthritis mice,” European Journal of Pharmacology, vol. 448, no. 2-3, pp. 231–238, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. M. G. Belvisi and J. A. Mitchell, “Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease,” British Journal of Pharmacology, vol. 158, no. 4, pp. 994–1003, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. E. J. Jeon, S. K. Lee, Y. S. Park, D. H. Kim, J. H. Yum, and C. S. Park, “The effects of Peroxisome Proliferator-Activated Receptor-γ agonist on a murine model of experimental allergic rhinitis,” Otolaryngology—Head and Neck Surgery, vol. 139, no. 1, pp. 124–130, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. D. J. Mangelsdorf, U. Borgmeyer, R. A. Heyman et al., “Characterization of three RXR genes that mediate the action of 9-cis retinoic acid,” Genes and Development, vol. 6, no. 3, pp. 329–344, 1992. View at Google Scholar · View at Scopus
  12. M. Kizaki, Y. Ikeda, R. Tanosaki et al., “Effects of novel retinoic acid compound, 9-cis-retinoic acid, on proliferation, differentiation, and expression of retinoic acid receptor-α and retinoid X receptor-α RNA by HL-60 cells,” Blood, vol. 82, no. 12, pp. 3592–3599, 1993. View at Google Scholar · View at Scopus
  13. D. J. Mangelsdorf and R. M. Evans, “The RXR heterodimers and orphan receptors,” Cell, vol. 83, no. 6, pp. 841–850, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. V. M. Manzano, J. C. S. Muñoz, J. R. Jiménez et al., “Human renal mesangial cells are a target for the anti-inflammatory action of 9-cis retinoic acid,” British Journal of Pharmacology, vol. 131, no. 8, pp. 1673–1683, 2000. View at Google Scholar · View at Scopus
  15. A. Diab, R. Z. Hussain, A. E. Lovett-Racke, J. A. Chavis, P. D. Drew, and M. K. Racke, “Ligands for the peroxisome proliferator-activated receptor-γ and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis,” Journal of Neuroimmunology, vol. 148, no. 1-2, pp. 116–126, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. K. Motomura, H. Sakai, H. Isobe, and H. Nawata, “Effects of retinoids on the production of tumour necrosis factor-α and nitric oxide by lipopolysaccharide stimulated rat Kupffer cells in vitro: evidence for participation of retinoid X receptor signalling pathway,” Cell Biochemistry and Function, vol. 15, no. 2, pp. 95–101, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Benson, S. Padmanabhan, T. W. Kurtz, and H. A. Pershadsingh, “Ligands for the peroxisome proliferator-activated receptor-γ and the retinoid X receptor-α exert synergistic antiproliferative effects on human coronary artery smooth muscle cells,” Molecular Cell Biology Research Communications, vol. 3, no. 3, pp. 159–164, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. B. S. Cha, T. P. Ciaraldi, L. Carter et al., “Peroxisome proliferator-activated receptor (PPAR) γ and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle,” Diabetologia, vol. 44, no. 4, pp. 444–452, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. J. Wan and M. Z. Badr, “Inhibition of carrageenan-induced cutaneous inflammation by PPAR agonists is dependent on hepatocyte-specific retinoid X receptor α,” PPAR Research, vol. 2006, Article ID 96341, pp. 1–6, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. S. Cuzzocrea, B. Pisano, L. Dugo et al., “Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-γ, reduces acute inflammation,” European Journal of Pharmacology, vol. 483, no. 1, pp. 79–93, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Posadas, M. Bucci, F. Roviezzo et al., “Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression,” British Journal of Pharmacology, vol. 142, no. 2, pp. 331–338, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. G. C. Ramos, D. Fernandes, C. T. Charão, D. G. Souza, M. M. Teixeira, and J. Assreuy, “Apoptotic mimicry: phosphatidylserine liposomes reduce inflammation through activation of peroxisome proliferator-activated receptors (PPARs) in vivo,” British Journal of Pharmacology, vol. 151, no. 6, pp. 844–850, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. G. D'Agostino, G. La Rana, R. Russo et al., “Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-α agonist, modulates carrageenan-induced paw edema in mice,” Journal of Pharmacology and Experimental Therapeutics, vol. 322, no. 3, pp. 1137–1143, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. K. Takamatsu, A. Takano, N. Yakushiji et al., “The first potent subtype-selective retinoid X receptor (RXR) agonist possessing a 3-isopropoxy-4-isopropylphenylamino moiety, NEt-3IP (RXRα/β-dual agonist),” ChemMedChem, vol. 3, no. 5, pp. 780–787, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. K. I. Morishita, N. Yakushiji, F. Ohsawa et al., “Replacing alkyl sulfonamide with aromatic sulfonamide in sulfonamide-type RXR agonists favors switch towards antagonist activity,” Bioorganic and Medicinal Chemistry Letters, vol. 19, no. 3, pp. 1001–1003, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. B. K. Taylor, N. Dadia, C. B. Yang, S. Krishnan, and M. Badr, “Peroxisome proliferator-activated receptor agonists inhibit inflammatory edema and hyperalgesia,” Inflammation, vol. 26, no. 3, pp. 121–127, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Youssef and M. Badr, “Role of peroxisome proliferator-activated receptors in inflammation control,” Journal of Biomedicine and Biotechnology, vol. 2004, no. 3, pp. 156–166, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. A. C. Oliveira, C. M. Bertollo, L. T. Rocha, E. B. Nascimento, K. A. Costa, and M. M. Coelho, “Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR α, and pioglitazone, an agonist of PPAR γ,” European Journal of Pharmacology, vol. 561, no. 1–3, pp. 194–201, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. Y. J. Wan, Y. Cai, W. Lungo et al., “Peroxisome proliferator-activated receptor α-mediated pathways are altered in hepatocyte-specific retinoid x receptor α-deficient mice,” Journal of Biological Chemistry, vol. 275, no. 36, pp. 28285–28290, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. S. Y. Na, B. Y. Kang, S. W. Chung et al., “Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFκB,” Journal of Biological Chemistry, vol. 274, no. 12, pp. 7674–7680, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Uchimura, M. Nakamuta, M. Enjoji et al., “Activation of retinoic X receptor and peroxisome proliferator-activated receptor-γ inhibits nitric oxide and tumor necrosis factor-α production in rat Kupffer cells,” Hepatology, vol. 33, no. 1, pp. 91–99, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. A. I. Shulman and D. J. Mangelsdorf, “Retinoid X receptor heterodimers in the metabolic syndrome,” New England Journal of Medicine, vol. 353, no. 6, pp. 604–615, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. L. S. Chan and R. A. Wells, “Cross-talk between PPARs and the partners of RXR: a molecular perspective,” PPAR Research, vol. 2009, Article ID 925309, 2009. View at Publisher · View at Google Scholar · View at PubMed
  34. M. Shimizu and H. Moriwaki, “Synergistic effects of PPARγ ligands and retinoids in cancer treatment,” PPAR Research, vol. 2008, Article ID 181047, 2008. View at Publisher · View at Google Scholar · View at PubMed
  35. A. I. Shulman, C. Larson, D. J. Mangelsdorf, and R. Ranganathan, “Structural determinants of allosteric ligand activation in RXR heterodimers,” Cell, vol. 116, no. 3, pp. 417–429, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Ijpenberg, N. S. Tan, L. Gelman et al., “In vivo activation of PPAR target genes by RXR homodimers,” EMBO Journal, vol. 23, no. 10, pp. 2083–2091, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. S. Kersten, B. Desvergne, and W. Wahli, “Roles of PPARS in health and disease,” Nature, vol. 405, no. 6785, pp. 421–424, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. Y. Wu and S. W. Guo, “Peroxisome proliferator-activated receptor-γ and retinoid X receptor agonists synergistically suppress proliferation of immortalized endometrial stromal cells,” Fertility and Sterility, vol. 91, no. 5, pp. 2142–2147, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. P. Desreumaux, L. Dubuquoy, S. Nutten et al., “Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor γ (PPARγ) heterodimer. A basis for new therapeutic strategies,” Journal of Experimental Medicine, vol. 193, no. 7, pp. 827–838, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. P. S. Burrage, A. C. Schmucker, Y. Ren, M. B. Sporn, and C. E. Brinckerhoff, “Retinoid X receptor and peroxisome proliferator-activated receptor-γ agonists cooperate to inhibit matrix metalloproteinase gene expression,” Arthritis Research and Therapy, vol. 10, no. 6, article R139, 2008. View at Publisher · View at Google Scholar · View at PubMed
  41. Y. Wang, A. H. Moser, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold, “Downregulation of liver X receptor-α in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines,” Journal of Lipid Research, vol. 46, no. 11, pp. 2377–2387, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. K. Harada, K. Isse, T. Kamihira, S. Shimoda, and Y. Nakanuma, “Th1 cytokine-induced downregulation of PPARγ in human biliary cells relates to cholangitis in primary biliary cirrhosis,” Hepatology, vol. 41, no. 6, pp. 1329–1338, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. A. P. Beigneux, A. H. Moser, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold, “The acute phase response is associated with retinoid X receptor repression in rodent liver,” Journal of Biological Chemistry, vol. 275, no. 21, pp. 16390–16399, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. Y. J. Wan, D. An, Y. Cai et al., “Hepatocyte-specific mutation establishes retinoid X receptor α as a heterodimeric integrator of multiple physiological processes in the liver,” Molecular and Cellular Biology, vol. 20, no. 12, pp. 4436–4444, 2000. View at Publisher · View at Google Scholar · View at Scopus